^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

KIT expression

i
Other names: KIT, C-Kit, CD117, PBT, SCFR, Stem Cell Factor Receptor, V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
Entrez ID:
Related tests:
15d
Pathologic diagnosis and molecular features of gastrointestinal stromal tumors: a mini-review. (PubMed, Front Oncol)
The standard treatment includes surgery and imatinib for metastatic cases; however, resistance to tyrosine kinase inhibitors remains a significant hurdle, especially in pediatric and wildtype GISTs. This highlights the need for advanced therapeutic strategies and emphasizes the importance of molecular profiling in guiding treatment decisions and improving outcomes for GIST patients.
Review • Journal • Stroma
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • PDGFRA (Platelet Derived Growth Factor Receptor Alpha) • ANO1 (Anoctamin 1)
|
KIT mutation • KIT expression
|
imatinib
17d
Primary Small Intestinal Leiomyosarcoma Presenting With Small Bowel Perforation: A Case Report. (PubMed, Cureus)
Due to the rarity of LMSs and their potential for misclassification, accurate diagnosis and multidisciplinary management are crucial. Given the high risk of recurrence and metastasis, particularly due to perforation, long-term follow-up is also recommended.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT expression
29d
A single-chain variable fragment-based bispecific T-cell activating antibody against CD117 enables T-cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cells. (PubMed, Hemasphere)
Additionally, in immunodeficient mice transplanted with healthy human HSPCs, the molecule decreased the number of CD117-positive cells in vivo. Therefore, bispecific CD117xCD3 targeting might be developed clinically in order to reduce CD117-expressing leukemia cells and HSPCs prior to HSCT.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT expression
29d
LNK/SH2B3 Loss Exacerbates the Development of Myeloproliferative Neoplasms in CBL-deficient Mice. (PubMed, Stem Cell Rev Rep)
Further analysis confirmed a positive role of LNK in regulating proteasome activity, independent of its well-established function in signaling transduction. Thus, our work reveals a novel function of LNK in coordinating with the E3 ligase CBL to regulate myeloid malignancies.
Preclinical • Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • SH2B3 (SH2B Adaptor Protein 3)
|
CBL mutation • JAK2 V617F • KIT expression
1m
4-Methyl-N-(Piperidin-1-Ylmethylene) Benzenesulfonamide (PMSA) Promotes Ferroptosis of Tumor Cells by Targeting the KEAP1-NRF2-GPX4 Axis. (PubMed, Iran J Public Health)
The KEAP1-NRF2-GPX4 axis was the target of PMSA's anti-tumor action, which results in ferroptosis of tumor cells. This demonstrated that the compound has the potential to be used as a candidate for anti-tumor drugs.
Journal • Tumor cell
|
KEAP1 (Kelch Like ECH Associated Protein 1) • GPX4 (Glutathione Peroxidase 4) • SLC7A11 (Solute Carrier Family 7 Member 11) • ANXA5 (Annexin A5)
|
KIT expression • SLC7A11 expression
1m
Patterns of expression of VEGFR2, PDGFRs and c-Kit in pediatric patients with high grade non-rhabdomyosarcoma soft tissue sarcoma. (PubMed, Front Oncol)
Our findings indicated that tyrosine kinase receptors are upregulated in NRSTS and exhibited a distinct expression pattern within various subgroups. High expression of VEGFR2 and PDGFRα significantly correlated with reduced survival and may guide targeted therapy approaches for this poor prognosis group of patients.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • PDGFRA (Platelet Derived Growth Factor Receptor Alpha) • KDR (Kinase insert domain receptor) • PDGFRB (Platelet Derived Growth Factor Receptor Beta)
|
KDR overexpression • KDR expression • KIT expression • PDGFRA expression
1m
Validating the APIS Breast Cancer Subtyping Kit: mRNA Expression of ER, PR, HER2, and Ki67 Compared to Immunohistochemistry in 374 Breast Cancer Core Needle Biopsies (AMP 2024)
A high level of agreement between IHC/ISH and mRNA expression determined by the APIS kit was observed for all markers. Subtype call agreement improved when Ki67 status was excluded, likely due to the challenges in distinguishing high and low Ki67 expression with IHC, leading to ambiguity in differentiating luminal B HER2- from luminal A tumours. Molecular subtyping offers additional insights for guiding breast cancer management decisions.
Biopsy
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 amplification • HER-2 negative • HER-2 expression • KIT expression • PGR expression
|
APIS Breast Cancer Subtyping Kit
2ms
Ononin delays the development of osteoarthritis by down-regulating MAPK and NF-κB pathways in rat models. (PubMed, PLoS One)
Our results demonstrated that ononin may ameliorate cartilage damage and inflammatory response in OA rats by downgrading MAPK and NF-κB pathways, thus identifying ononin as a potential novel drug to treat OA.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL1B (Interleukin 1, beta) • MAPK8 (Mitogen-activated protein kinase 8)
|
KIT expression
2ms
Regulation of BCR-dependent germinal center B-cell formation by HGAL and insight into its emerging myeloid ortholog, C1ORF150. (PubMed, Front Immunol)
Intriguingly, recent GWAS studies have identified a C1ORF150 in-frame splice variant that is strongly associated with urticaria. Candidate mechanisms via which the encoded "C1ORF150-Δexon2" isoform affects mast cell degranulation are considered, including FcϵR1 and/or KIT receptor connections, and candidate "myristoylation switch" mechanisms.
Review • Journal
|
RHOA (Ras homolog family member A) • SYK (Spleen tyrosine kinase)
|
KIT expression
2ms
Gastrointestinal Stromal Tumors: Variants and Some Pitfalls That They Create. (PubMed, Adv Anat Pathol)
It is also important to consider morphologic and immunophenotypic changes associated with treatment, including the potential absence of kit expression, particularly in GISTs that have metastasized. Therefore, obtaining clinical information regarding prior therapy with a tyrosine kinase inhibitor (TKI) is crucial.
Review • Journal • Stroma
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • PDGFRA (Platelet Derived Growth Factor Receptor Alpha) • SDHB (Succinate Dehydrogenase Complex Iron Sulfur Subunit B) • ANO1 (Anoctamin 1)
|
PDGFRA mutation • KIT expression
2ms
Investigation of the Theragnostic Role of KIT Expression for the Treatment of Canine Mast Cell Tumors with Tyrosine Kinase Inhibitors. (PubMed, Vet Sci)
A statistical analysis was performed to assess the overall survival status. Our data suggest an important role of KIT in the etiopathogenesis of canine MCTs and indicate that the anomalous cytoplasmatic distribution of KIT is potentially related to a lower efficacy of tyrosine kinase inhibitors, thus providing a significant prognostic information about the treatment outcome.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT expression
2ms
SALL4 and C-kit positive malignant extrarenal rhabdoid tumor of the pelvis in a child: A diagnostic and therapeutic challenge. (PubMed, J Cancer Res Ther)
A complete immunohistochemical workup might help in differentiating ERRTs from other SMARCB1/INI1-deficient soft tissue tumors. The expression of stem cell markers in the presented case also suggests that these tumors might originate from or share similarities with embryonic stem cells or germ cells.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • SMARCB1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily B, Member 1) • SALL4 (Spalt Like Transcription Factor 4)
|
KIT positive • KIT expression
2ms
Novel deoxyhypusine synthase (DHPS) inhibitors target hypusination-induced vasculogenic mimicry (VM) against malignant melanoma. (PubMed, Pharmacol Res)
Pharmacokinetic evaluations demonstrated 7k's favorable properties, and xenograft models evidenced its notable anti-melanoma efficacy, achieving a TGI of 73%. These results highlighted DHPS as key in melanoma VM formation and confirmed 7k's potential as a novel anti-melanoma agent.
Journal
|
FGFR2 (Fibroblast growth factor receptor 2) • KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT expression • FGFR2 expression
2ms
MicroRNA expression signature in gastrointestinal stromal tumour & their molecular & histological features. (PubMed, Indian J Med Res)
Interpretation & conclusions The present study showed that the down-regulation of these miRNAs may help better molecular classification and characterization of GISTs. Our results offer new insight into the association between miRNAs and histological features, enabling a more thorough understanding of GISTs at the molecular level.
Journal • Stroma
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • PDGFRA (Platelet Derived Growth Factor Receptor Alpha) • MIR34A (MicroRNA 34a-5p) • MIR221 (MicroRNA 221) • MIR494 (MicroRNA 494) • MIR222 (MicroRNA 222)
|
KIT exon 11 mutation • PDGFRA mutation • KIT expression
2ms
Evaluation of CD56 and CD117 Double-positive as a Predictor of Poor Prognosis in Multiple Myeloma Patients: A Retrospective Analysis. (PubMed, Turk J Haematol)
The high cytogenetic risk was found to bean independent predictor of shorter OS (p>0.001). The study's findings revealed that CD56 and CD117 double- positive MM patients had poorer prognosis, lower ORR, shorter OS, and higher mortality.
Retrospective data • Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • NCAM1 (Neural cell adhesion molecule 1)
|
KIT expression • NCAM1 positive
2ms
Systemic treatments in recurrent or metastatic salivary gland cancer: a systematic review. (PubMed, ESMO Open)
Systemic treatments contribute to the survival of patients with salivary gland cancer at relapsed or newly advanced stages. The response to treatment is heavily influenced by histological subtype and treatment specificity.
Review • Journal • Metastases
|
AR (Androgen receptor)
|
HER-2 overexpression • AR overexpression • AR expression • KIT expression
|
Herceptin (trastuzumab) • bicalutamide
3ms
Immunohistochemical Analysis of CD117 in the Mast Cells of Odontogenic Keratocysts. (PubMed, Cureus)
Our study concluded that MCs were present in increased numbers both in the superficial and deep connective tissue of recurrent OKCs, indicative of their aggressive clinical behaviour. Increased mean MC counts observed in some of the sporadic cases may be an indicator of their chances of recurrence in the future.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT expression
3ms
Enhancing HER2 evaluation: correlation between APIS breast cancer subtyping kit and IHC/ISH for accurate HER2 quantification (ECP 2024)
The APIS Breast Cancer Subtyping Kit accurately detects HER2/ERBB2 expression. The findings suggest that relying solely on IHC categorisation may not suffice for predicting response to novel anti-HER2 treatments. Utilising additional cut-offs could enhance the stratification of ERBB2 mRNA expression, distinguishing a ‘HER2- low’ group.
HER-2 (Human epidermal growth factor receptor 2)
|
HER-2 amplification • HER-2 negative • HER-2 expression • HER-2 underexpression • KIT expression
|
APIS Breast Cancer Subtyping Kit
3ms
C-Kit Immunohistochemical Expression as a Complementary Method to Assess Mast Cell Density in Helicobacter Pylori-mediated Gastritis. (PubMed, Digestion)
Regions that exhibit severe inflammation, metaplasia, atrophy, and carcinoma demonstrated an increase in MCD with H. pylori-mediated gastritis. A detailed investigation in clinical practice to screen early diagnosis and treatment needs to be performed in high H. pylori prevalence.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT expression
3ms
Leucocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications. (PubMed, Br J Haematol)
All cases were successfully managed with hydroxyurea...In conclusion, APL patients undergoing ATRA-ATO therapy with lower fibrinogen levels and platelet counts at diagnosis and with a massive bone marrow blast infiltrate should be carefully monitored for the development of leucocytosis during induction. DS and other treatment-related complications seem to occur almost exclusively in patients developing leucocytosis, who should necessarily receive DS prophylaxis and more intensive monitoring and supportive therapy to prevent treatment complications.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT expression
|
Vesanoid (tretinoin) • arsenic trioxide • hydroxyurea
3ms
LINC01232 promotes ARNTL2 transcriptional activation and inhibits ferroptosis of CRC cells through p300/H3K27ac. (PubMed, Epigenomics)
Chromatin immunoprecipitation and RNA immunoprecipitation analysis monitored the correlation among LINC01232, H3K27ac, p300 and ARNTL2. LINC01232 or ARNTL2 knockdown facilitated erastin-induced ferroptosis. The interaction between LINC01232 and p300 resulted in the enhancement of H3K27ac levels at ARNTL2 promoter to promote ARNTL2 transcriptional activity. ARNTL2 overexpression reversed the promoting effect of LINC01232 knockdown on ferroptosis. LINC01232 inhibited the ferroptosis in CRC by epigenetically upregulating the transcriptional activity of ARNTL2.
Journal
|
ARNTL (Aryl Hydrocarbon Receptor Nuclear Translocator Like)
|
KIT expression
|
erastin
3ms
Rare Double Primary Malignancies: A Pancreatic Gastrointestinal Stromal Tumor Mimicking as a Metastatic Lesion of Myoepithelial Carcinoma of Parotid Gland. (PubMed, Case Rep Med)
Subsequently, a splenic-sparing distal pancreatectomy was performed, followed by immediate imatinib therapy...When encountering a newly developed lesion in a distant organ, surgeons must consider the possibility of metastasis to guide therapeutic decision-making. Early diagnosis and appropriate intervention are paramount, particularly in the case of PGIST, given its infrequent presentation and clinical complexities.
Journal • Stroma • Metastases
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • CD34 (CD34 molecule)
|
KIT expression
|
imatinib
3ms
Sendai virus-mediated RNA delivery restores fertility to congenital and chemotherapy-induced infertile female mice. (PubMed, PNAS Nexus)
This virus also effectively addressed iatrogenic infertility induced by busulfan, a widely used cancer chemotherapy agent. Offspring born through SeV administration and natural mating displayed normal genomic imprinting patterns and fertility. Since SeVs pose no genotoxicity risk, the successful restoration of fertility by SeVs represents a promising approach for treating congenital infertility with somatic cell defects and protecting fertility of cancer patients who may become infertile due to loss of oocytes during cancer therapy.
Preclinical • Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT expression
|
busulfan
7ms
Extraskeletal Ewing Sarcoma of the Gastrointestinal and Hepatobiliary Tract: Deceptive Immunophenotype Commonly Leads to Misdiagnosis. (PubMed, Am J Surg Pathol)
Our data indicate ES in the GI and hepatobiliary tract is commonly misdiagnosed leading to a delay in therapy. In light of the attendant therapeutic and prognostic implications, ES should be considered in the differential diagnosis of any GI or hepatobiliary tumor with epithelioid and/or small round cell morphology.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • EWSR1 (EWS RNA Binding Protein 1) • SYP (Synaptophysin)
|
KIT expression
8ms
Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer. (PubMed, Front Immunol)
Receiver operating characteristic curve analysis demonstrated that incorporating unfavorable genotypes and clinicopathological variables improved the ability to predict EBC survival (P = 0.006, 0.004, 0.029, and 0.019 for iDFS, DDFS, BCSS, and OS, respectively). Additionally, rs6753785 and rs2213181 were associated with BCL2L11 and c-Kit mRNA expression, respectively. Our results suggest that these four SNPs may act as novel biomarkers for EBC survival, possibly by modulating the expression of the corresponding genes.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • BCL2L11 (BCL2 Like 11) • ATG2B (Autophagy Related 2B)
|
KIT expression
8ms
Plasma Circulating Terminal Differentiation-Induced Non-Coding RNA Serves as a Biomarker in Breast Cancer. (PubMed, Int J Hematol Oncol Stem Cell Res)
Plasma TINCR level was also positively correlated with the diagnostic age of breast cancer patients. A low level of plasma TINCR could discriminate breast cancer patients from healthy control subjects.
Journal
|
TINCR (TINCR Ubiquitin Domain Containing)
|
KIT expression
8ms
New treatment strategies for uterine sarcoma using secreted frizzled‑related proteins. (PubMed, Exp Ther Med)
In conclusion, SFRP4 may suppress the viability and migration, and enhance the adhesion of sarcoma cells. These results suggested that SFRP4 could be considered as a novel therapeutic target for uterine sarcoma.
Journal
|
SFRP4 (Secreted frizzled-related protein 4)
|
KIT expression
8ms
Aberrant METTL14 gene expression contributes to malignant transformation of benzene-exposed myeloid cells. (PubMed, Ecotoxicol Environ Saf)
This upregulation of target gene expression activated signalling pathways such as mTOR-AKT, ultimately resulting in malignant proliferation of bone marrow cells. In conclusion, this study offers insights into potential early targets for benzene-induced haematologic malignant diseases and provides novel perspectives for more targeted preventive and therapeutic strategies.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • mTOR (Mechanistic target of rapamycin kinase) • METTL14 (Methyltransferase 14)
|
KIT expression • KIT overexpression
9ms
Trial completion date • Stroma
|
KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT expression
|
sorafenib • imatinib • sunitinib
9ms
Cuscuta chinensis flavonoids alleviate ovarian damage in offspring female mice induced by BPA exposure during pregnancy by regulating the central carbon metabolism pathway. (PubMed, Ecotoxicol Environ Saf)
In summary, CCFs alleviate BPA-induced ovarian damage in offspring female mice by regulating the central carbon metabolism pathway. This study will improve the information on BPA reproductive damage antagonist drugs and provide a theoretical basis for protecting animal reproductive health.
Preclinical • Journal
|
TP53 (Tumor protein P53) • KIT (KIT proto-oncogene, receptor tyrosine kinase) • HRAS (Harvey rat sarcoma viral oncogene homolog) • SIRT3 (Sirtuin 3) • SIRT6 (Sirtuin 6) • CAT (Catalase) • PKM (Pyruvate Kinase M1/2) • TIGAR (TP53 Induced Glycolysis Regulatory Phosphatase)
|
KIT expression
9ms
Selective Recognition of c-KIT 1 G-Quadruplex by Structural Tuning of Heteroaromatic Scaffolds and Side Chains. (PubMed, ACS Med Chem Lett)
Biological studies demonstrate that MC-4 efficiently enters cells, reduces c-KIT gene expression, and induces cell cycle arrest, DNA damage, and apoptosis in cancer cells. These findings demonstrate MC-4 as a selective c-KIT G4 ligand with therapeutic potential, providing insight into the structural basis of its anticancer mechanisms.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT expression
9ms
Kaempferol ameliorated alcoholic hepatitis through improving intestinal barrier function by targeting miRNA-155 signaling. (PubMed, Pharmacology)
Kaempferol improved the stability of gut barrier function to ameliorate hepatic injury induced by alcohol intake through enhancing occludin protein expression, by targeting miR-155 to inhibit the excessive inflammatory response in the intestine.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • MIR155 (MicroRNA 155) • SOCS1 (Suppressor Of Cytokine Signaling 1) • IL1B (Interleukin 1, beta) • TJP1 (Tight Junction Protein 1) • OCLN (Occludin)
|
KIT expression
10ms
KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST. (PubMed, Cell Commun Signal)
Clinically, about 80-90% of treatment-naive GIST patients harbor primary KIT mutations, and special KIT-targeted TKI, imatinib (IM) showing dramatic efficacy but resistance invariably occur, 90% of them was due to the second resistance mutations emerging within the KIT gene...In this review, we elucidate the biologic mechanism of KIT variants and update the underlying mechanism of the expression of KIT gene, which are exclusively regulated in GIST, providing a promising yet evidence-based therapeutic landscape and possible target for the conquer of IM resistance. Video Abstract.
Review • Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
KIT mutation • KIT expression
|
imatinib
10ms
Journal
|
FLT3 (Fms-related tyrosine kinase 3) • KIT (KIT proto-oncogene, receptor tyrosine kinase)
|
FLT3 mutation • KIT expression
10ms
An integrative proteomics approach identifies tyrosine kinase KIT as a therapeutic target for SPINK1-positive prostate cancer. (PubMed, iScience)
Notably, inhibiting KIT signaling led to restoration of AR/REST levels, forming a feedback loop enabling SPINK1 repression. Overall, we uncover the role of KIT signaling downstream of SPINK1 in maintaining lineage plasticity and provide distinct treatment modalities for advanced-stage SPINK1-positive patients.
Journal
|
SPINK1 (Serine peptidase inhibitor, kazal type 1)
|
KIT expression
10ms
Comprehensive Molecular Profiling of Breast Cancer: A Real-time PCR Assay for Identifying ESR1, PGR, ERBB2, MKI67 and a Novel Proliferative Signature in Core Needle Biopsies and Resected Tissues from Patients with Invasive Breast Cancer (USCAP 2024)
High level of agreement between IHC/ISH and APIS Breast Cancer Subtyping Kit mRNA expression was observed for all markers, successfully demonstrating APIS Breast Cancer Subtyping Kit's strong clinical accuracy. The overlap observed in ERBB2 confirms that IHC stratification may not be an adequate method for predicting the response to novel anti-HER2 therapies and suggests that incorporating continuous quantification of HER2 could optimize patient outcomes.
Clinical • Biopsy
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 overexpression • HER-2 expression • KIT expression
|
APIS Breast Cancer Subtyping Kit
10ms
Asperuloside alleviates cyclophosphamide-induced myelosuppression by promoting AMPK/mTOR pathway-mediated autophagy. (PubMed, J Biochem Mol Toxicol)
Cyclophosphamide (CTX) is a common anticancer chemotherapy drug, and myelosuppression is the most common serious side effect. The use of dorsomorphin inhibited the alleviation effect of ASP on CTX-induced myelosuppression and the promotion effect of ASP on autophagy. In conclusion, ASP alleviated CTX-induced myelosuppression by promoting AMPK/mTOR pathway-mediated autophagy.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • CSF2 (Colony stimulating factor 2) • BECN1 (Beclin 1)
|
KIT expression • AMPK expression
|
cyclophosphamide • dorsomorphin (Compound C)
11ms
An in vitro three-dimensional (3D) testicular organoid culture system for efficient gonocyte maintenance and propagation using frozen/thawed neonatal bovine testicular tissues. (PubMed, Biomed Mater)
These organoids could be cryopreserved for storage and thawed as needed. The successful generation of ITT organoids provides a valuable tool for establishing in vitro spermatogenesis, propagating human germ cells, investigating testicular physiology and the origin of germ cell tumors, and testing the toxicity of new drugs in future clinical applications.
Preclinical • Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • FGF2 (Fibroblast Growth Factor 2) • GFRA1 (GDNF Family Receptor Alpha 1) • LIF (LIF Interleukin 6 Family Cytokine)
|
KIT expression
11ms
A Case of Primary Liver Cancer and Gastric Glomus Tumor Diagnosed Preoperatively and Treated with Liver Segmentectomy and Local Gastrectomy (PubMed, Gan To Kagaku Ryoho)
Therefore, a diagnosis of a Glomus tumor of the stomach was made. Gastric Glomus tumors are very rare; therefore, we have reviewed some citations and would like to discuss our case.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • CD34 (CD34 molecule)
|
KIT expression
11ms
Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment. (PubMed, Genes (Basel))
Further studies on the pathobiology of mast cells can lead to clinical improvements, such as better MCT diagnosis and treatment. Our paper reviews studies on the topic of mast cells, which have been carried out over the past few years.
Review • Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • MIR21 (MicroRNA 21) • MIR885 (MicroRNA 885)
|
KIT expression • KIT D816H
11ms
Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication. (PubMed, Pathol Res Pract)
Moreover, stem cell factor (SCF; also known as KIT ligand, KITL) induced ERK activation in ACC cells. These results suggest that inactivation of Wnt/β-catenin signaling may promote C-kit-ERK signaling and cell proliferation of in metastatic ACC.
Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • NFIB (Nuclear Factor I B) • MYBL1 (MYB Proto-Oncogene Like 1) • SEMA3A (Semaphorin 3A)
|
KIT expression
11ms
Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells. (PubMed, J Ethnopharmacol)
The findings indicate that Rg1 significantly ameliorates chronic liver damage and fibrosis induced by LPS. The mechanism may be mediated through promoting the dissociation of Nrf2 from Keap1 and then activating Nrf2 signaling and further inhibiting NLRP3, NLRP1, and AIM2 inflammasomes in liver cells.
Journal
|
KEAP1 (Kelch Like ECH Associated Protein 1) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • NQO1 (NAD(P)H dehydrogenase, quinone 1) • IL1B (Interleukin 1, beta) • NLRP3 (NLR Family Pyrin Domain Containing 3)
|
KIT expression • KEAP1 expression